Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 4Completed 4Terminated 2Recruiting 2Active not recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1CNS 1

Conditions

Solid Tumor 1Glioblastoma 1

Interventions

pembrolizumab 555Specimen Handling 459Carboplatin 446Magnetic Resonance Spectroscopy 427Cyclophosphamide 412Cisplatin 404Gemcitabine 314Radiotherapy 313Bevacizumab 310Paclitaxel 300Biopsy 260Drug Therapy 252Capecitabine 241Oxaliplatin 240fludarabine 236Nivolumab 226venetoclax 225Injections 214Docetaxel 203Fluorouracil 201Dexamethasone 186Radiosurgery 172Rituximab 161Pemetrexed 157durvalumab 144Standard of Care 143atezolizumab 139toripalimab 137tislelizumab 137Leucovorin 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Interventional × Re-Irradiation × Clear all
NCT05904119 2026-02-17

LEGATO

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting
411 enrolled
CNS

Glioblastoma

NCT05301101 2025-06-29

REDIRICT

Medical College of Wisconsin

Phase NA Recruiting
120 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡